Small bowel adenocarcinomas-existing evidence and evolving paradigms

Nature Reviews Clinical Oncology

Volumn 10, Issue 9, 2013, Pages 534-544

  Raghav, Kanwal ^a   Overman, Michael J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; BETA CATENIN; BEVACIZUMAB; CA 19-9 ANTIGEN; CAPECITABINE; CARCINOEMBRYONIC ANTIGEN; CISPLATIN; DOXORUBICIN; ERLOTINIB; FLUOROPYRIMIDINE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IRINOTECAN; K RAS PROTEIN; OXALIPLATIN; PACLITAXEL; PANITUMUMAB; PROTEIN MLH1; PROTEIN P53; WNT PROTEIN;

ADENOCARCINOMA; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CAPSULE ENDOSCOPY; CARCINOGENESIS; CHROMOSOME 18Q; CHROMOSOME LOSS; CLINICAL FEATURE; COLORECTAL CARCINOMA; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; EVIDENCE BASED MEDICINE; FAMILIAL CANCER; GENE MUTATION; HUMAN; IMMUNOPHENOTYPING; INTESTINE ENDOSCOPY; INTESTINE RADIOGRAPHY; METASTASIS; MICROSATELLITE INSTABILITY; MOLECULAR PATHOLOGY; ONCOGENE K RAS; PRIORITY JOURNAL; PROTEIN METHYLATION; RARE DISEASE; REVIEW; SIGNAL TRANSDUCTION; SMALL BOWEL ADENOCARCINOMA; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; EVIDENCE-BASED MEDICINE; HUMANS; INTESTINAL NEOPLASMS; INTESTINE, SMALL;

EID: 84883463354     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2013.132     Document Type: Review

References (124)

1. Hatzaras, I. et al. Small-bowel tumours: Epidemiologic and clinical characteristics of 1260 cases from the connecticut tumour registry. Arch. Surg. 142, 229-235 2007
2. Schottenfeld, D., Beebe-Dimmer, J. L. & Vigneau, F. D. The epidemiology and pathogenesis of neoplasia in the small intestine. Ann. Epidemiol. 19, 58-69 2009
3. Chow, J. S., Chen, C. C., Ahsan, H. & Neugut, A. I. A population-based study of the incidence of malignant small bowel tumours: SEER, 1973-1990. Int. J. Epidemiol. 25, 722-728 1996
4. Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2013. CA Cancer J. Clin. 63, 11-30 2013
5. Bilimoria, K. Y. et al. Small bowel cancer in the United States: Changes in epidemiology, treatment, and survival over the last 20 years. Ann. Surg. 249, 63-71 2009
6. Lu, Y., Frobom, R. & Lagergren, J. Incidence patterns of small bowel cancer in a population-based study in Sweden: Increase in duodenal adenocarcinoma. Cancer Epidemiol. 36, e158-e163 2012
7. Haselkorn, T., Whittemore, A. S. & Lilienfeld, D. E. Incidence of small bowel cancer in the United States and worldwide: geographic, temporal, and racial differences. Cancer Causes Control 16, 781-787 2005
8. Howe, J. R., Karnell, L. H., Menck, H. R. & Scott-Conner, C. The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: Review of the National Cancer Data Base, 1985-1995. Cancer 86, 2693-2706 1999
9. Halfdanarson, T. R., McWilliams, R. R., Donohue, J. H. & Quevedo, J. F. A single-institution experience with 491 cases of small bowel adenocarcinoma. Am. J. Surg. 199, 797-803 2010
10. Chang, H. K. et al. Adenocarcinoma of the small intestine: A multi-institutional study of 197 surgically resected cases. Hum. Pathol. 41, 1087-1096 2010
11. Goodman, M. T., Matsuno, R. K. & Shvetsov, Y. B. Racial and ethnic variation in the incidence of small-bowel cancer subtypes in the United States, 1995-2008. Dis. Colon Rectum 56, 441-448 2013
12. Overman, M. J. et al. A population-based comparison of adenocarcinoma of the large and small intestine: Insights into a rare disease. Ann. Surg. Oncol. 19, 1439-1445 2012
13. Rodriguez-Bigas, M. A. et al. Characteristics of small bowel carcinoma in hereditary nonpolyposis colorectal carcinoma. International Collaborative Group on HNPCC. Cancer 83, 240-244 1998
14. Giardiello, F. M. et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 119, 1447-1453 2000
15. Koornstra, J. J. et al. Management of extracolonic tumours in patients with Lynch syndrome. Lancet Oncol. 10, 400-408 2009
16. ten Kate, G. L. et al. Is surveillance of the small bowel indicated for Lynch syndrome families? Gut 56, 1198-1201 2007
17. Galiatsatos, P. & Foulkes, W. D. Familial adenomatous polyposis. Am. J. Gastroenterol. 101, 385-398 2006
18. Centre, M. M., Jemal, A. & Ward, E. International trends in colorectal cancer incidence rates. Cancer Epidemiol. Biomarkers Prev. 18, 1688-1694 2009
19. Dabaja, B. S., Suki, D., Pro, B., Bonnen, M. & Ajani, J. Adenocarcinoma of the small bowel: Presentation, prognostic factors, and outcome of 217 patients. Cancer 101, 518-526 2004
20. Sellner, F. Investigations on the significance of the adenoma-carcinoma sequence in the small bowel. Cancer 66, 702-715 1990
21. Perzin, K. H. & Bridge, M. F. Adenomas of the small intestine: A clinicopathologic review of 51 cases and a study of their relationship to carcinoma. Cancer 48, 799-819 1981
22. Vogelstein, B. et al. Genetic alterations during colorectal-tumour development. N. Engl. J. Med. 319, 525-532 1988
23. Haan, J. C. et al. Small bowel adenocarcinoma copy number profiles are more closely related to colorectal than to gastric cancers. Ann. Oncol. 23, 367-374 2012
24. Chan, O. T. et al. Lack of HER2 overexpression and amplification in small intestinal adenocarcinoma. Am. J. Clin. Pathol. 134, 880-885 2010
25. Kountourakis, P. et al. Clinicopathologic significance of EGFR and Her-2/neu in colorectal adenocarcinomas. Cancer J. 12, 229-236 2006
26. Shitara, K. et al. Prognosis of patients with advanced gastric cancer by HER2 status and trastuzumab treatment. Gastric Cancer 16, 261-267 2012
27. DeSesso, J. M. & Jacobson, C. F. Anatomical and physiological parameters affecting gastrointestinal absorption in humans and rats. Food Chem. Toxicol. 39, 209-228 2001
28. Lowenfels, A. B. Why are small-bowel tumours so rare? Lancet 1, 24-26 1973
29. Calman, K. C. Why are small bowel tumours rare? An experimental model. Gut 15, 552-554 1974
30. Blaker, H. et al. Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas. Scand. J. Gastroenterol. 39, 748-753 2004
31. Miyaki, M. et al. Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumours. Cancer Res. 54, 3011-3020 1994
32. Pan, S. Y. & Morrison, H. Epidemiology of cancer of the small intestine. World J. Gastrointest. Oncol. 3, 33-42 2011
33. Green, P. H. & Cellier, C. Celiac disease. N. Engl. J. Med. 357, 1731-1743 2007
34. Jess, T., Winther, K. V., Munkholm, P., Langholz, E. & Binder, V. Intestinal and extra-intestinal cancer in Crohn's disease: Follow-up of a population-based cohort in Copenhagen County, Denmark. Aliment. Pharmacol. Ther. 19, 287-293 2004
35. Jess, T., Gamborg, M., Matzen, P., Munkholm, P. & Sorensen, T. I. Increased risk of intestinal cancer in Crohn's disease: A meta-analysis of population-based cohort studies. Am. J. Gastroenterol. 100, 2724-2729 2005
36. Green, P. H. et al. Risk of malignancy in patients with celiac disease. Am. J. Med. 115, 191-195 2003
37. Wu, A. H., Yu, M. C. & Mack, T. M. Smoking, alcohol use, dietary factors and risk of small intestinal adenocarcinoma. Int. J. Cancer 70, 512-517 1997
38. Negri, E. et al. Risk factors for adenocarcinoma of the small intestine. Int. J. Cancer 82, 171-174 1999
39. Kaerlev, L. et al. Is there an association between alcohol intake or smoking and small bowel adenocarcinoma? Results from a European multi-centre case-control study. Cancer Causes Control 11, 791-797 2000
40. Boffetta, P. et al. Body mass, tobacco smoking, alcohol drinking and risk of cancer of the small intestine - A pooled analysis of over 500,000 subjects in the Asia Cohort Consortium. Ann. Oncol. 23, 1894-1898 2012
41. Chen, C. C., Neugut, A. I. & Rotterdam, H. Risk factors for adenocarcinomas and malignant carcinoids of the small intestine: Preliminary findings. Cancer Epidemiol. Biomarkers Prev. 3, 205-207 1994
42. Chow, W. H. et al. Risk factors for small intestine cancer. Cancer Causes Control 4, 163-169 1993
43. Cross, A. J. et al. A prospective study of meat and fat intake in relation to small intestinal cancer. Cancer Res. 68, 9274-9279 2008
44. Schatzkin, A., Park, Y., Leitzmann, M. F., Hollenbeck, A. R. & Cross, A. J. Prospective study of dietary fibre, whole grain foods, and small intestinal cancer. Gastroenterology 135, 1163-1167 2008
45. Wolk, A. et al. A prospective study of obesity and cancer risk Sweden. Cancer Causes Control 12, 13-21 2001
46. Samanic, C. et al. Obesity and cancer risk among white and black United States veterans. Cancer Causes Control 15, 35-43 2004
47. Bjørge, T., Tretli, S. & Engeland, A. Height and body mass index in relation to cancer of the small intestine in two million Norwegian men and women. Br. J. Cancer 93, 807-810 2005
48. Jagelman, D. G., DeCosse, J. J. & Bussey, H. J. Upper gastrointestinal cancer in familial adenomatous polyposis. Lancet 1, 1149-1151 1988
49. Saurin, J. C. et al. Surveillance of duodenal adenomas in familial adenomatous polyposis reveals high cumulative risk of advanced disease. J. Clin. Oncol. 22, 493-498 2004
50. Fu, T. et al. CpG island methylator phenotype-positive tumours in the absence of MLH1 methylation constitute a distinct subset of duodenal adenocarcinomas and are associated with poor prognosis. Clin. Cancer Res. 18, 4743-4752 2012
51. Rashid, A. & Hamilton, S. R. Genetic alterations in sporadic and Crohn's-associated adenocarcinomas of the small intestine. Gastroenterology 113, 127-135 1997
52. Wheeler, J. M. et al. An insight into the genetic pathway of adenocarcinoma of the small intestine. Gut 50, 218-223 2002
53. Miyoshi, Y. et al. Somatic mutations of the APC gene in colorectal tumours: Mutation cluster region in the APC gene. Hum. Mol. Genet. 1, 229-233 1992
54. Diosdado, B. et al. High-resolution array comparative genomic hybridization in sporadic and celiac disease-related small bowel adenocarcinomas. Clin. Cancer Res. 16, 1391-1401 2010
55. Lee, H. J. et al. Combined loss of E-cadherin and aberrant beta-catenin protein expression correlates with a poor prognosis for small intestinal adenocarcinomas. Am. J. Clin. Pathol. 139, 167-176 2013
56. Murata, M. et al. Molecular and biological analysis of carcinoma of the small intestine: Beta-catenin gene mutation by interstitial deletion involving exon 3 and replication error phenotype. Am. J. Gastroenterol. 95, 1576-1580 2000
57. Bläker, H., von Herbay, A., Penzel, R., Gross, S. & Otto, H. F. Genetics of adenocarcinomas of the small intestine: Frequent deletions at chromosome 18q and mutations of the SMAD4 gene. Oncogene 21, 158-164 2002
58. Breuhahn, K., Singh, S., Schirmacher, P. & Blaker, H. Large-scale N-terminal deletions but not point mutations stabilize beta-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesis. J. Pathol. 215, 300-307 2008
59. Ilyas, M., Tomlinson, I. P., Rowan, A., Pignatelli, M. & Bodmer, W. F. Beta-catenin mutations in cell lines established from human colorectal cancers. Proc. Natl Acad. Sci. USA 94, 10330-10334 1997
60. Cho, K. R. et al. The DCC gene: Structural analysis and mutations in colorectal carcinomas. Genomics 19, 525-531 1994
61. Reiss, M., Santoro, V., de Jonge, R. R. & Vellucci, V. F. Transfer of chromosome 18 into human head and neck squamous carcinoma cells: Evidence for tumour suppression by Smad4/DPC4. Cell Growth Differ. 8, 407-415 1997
62. Thiagalingam, S. et al. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat. Genet. 13, 343-346 1996
63. Svrcek, M. et al. Immunohistochemical analysis of adenocarcinoma of the small intestine: A tissue microarray study. J. Clin. Pathol. 56, 898-903 2003
64. Blaker, H. et al. Loss of SMAD4 function in small intestinal adenocarcinomas: Comparison of genetic and immunohistochemical findings. Pathol. Res. Pract. 200, 1-7 2004
65. Nishiyama, K. et al. Overexpression of p53 protein and point mutation of K-ras genes in primary carcinoma of the small intestine. Oncol. Rep. 9, 293-300 2002
66. Boland, C. R. et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 58, 5248-5257 1998
67. Overman, M. J. et al. Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine. Br. J. Cancer 102, 144-150 2010
68. Planck, M. et al. Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine. Cancer 97, 1551-1557 2003
69. Potter, D. D. et al. The role of defective mismatch repair in small bowel adenocarcinoma in celiac disease. Cancer Res. 64, 7073-7077 2004
70. Minardi, A. J. Jr, Zibari, G. B., Aultman, D. F., McMillan, R. W. & McDonald, J. C. Small-bowel tumours. J. Am. Coll. Surg. 186, 664-668 1998
71. Talamonti, M. S., Goetz, L. H., Rao, S. & Joehl, R. J. Primary cancers of the small bowel: Analysis of prognostic factors and results of surgical management. Arch. Surg. 137, 564-570 2002
72. Zaanan, A. et al. Chemotherapy of advanced small-bowel adenocarcinoma: A multicenter AGEO study. Ann. Oncol. 21, 1786-1793 2010
73. Maglinte, D. D., O?Connor, K., Bessette, J., Chernish, S. M. & Kelvin, F. M. The role of the physician in the late diagnosis of primary malignant tumours of the small intestine. Am. J. Gastroenterol. 86, 304-308 1991
74. Bessette, J. R., Maglinte, D. D., Kelvin, F. M. & Chernish, S. M. Primary malignant tumors in the small bowel: A comparison of the small-bowel enema and conventional follow-through examination. AJR Am. J. Roentgenol. 153, 741-744 1989
75. Dudiak, K. M., Johnson, C. D. & Stephens, D. H. Primary tumors of the small intestine: CT evaluation. AJR Am. J. Roentgenol. 152, 995-998 1989
76. Pilleul, F. et al. Possible small-bowel neoplasms: Contrast-enhanced and water-enhanced multidetector CT enteroclysis. Radiology 241, 796-801 2006
77. Van Weyenberg, S. J. et al. MR enteroclysis in the diagnosis of small-bowel neoplasms. Radiology 254, 765-773 2010
78. Minordi, L. M., Vecchioli, A., Mirk, P. & Bonomo, L. CT enterography with polyethylene glycol solution vs CT enteroclysis in small bowel disease. Br. J. Radiol. 84, 112-119 2011
79. Laurent, F. et al. Diagnosis and categorization of small bowel neoplasms: Role of computed tomography. Gastrointest. Radiol. 16, 115-119 1991
80. Cronin, C. G. et al. Utility of positron emission tomography/CT in the evaluation of small bowel pathology. Br. J. Radiol. 85, 1211-1221 2012
81. Fry, L. C., Bellutti, M., Neumann, H., Malfertheiner, P. & Monkemuller, K. Incidence of bleeding lesions within reach of conventional upper and lower endoscopes in patients undergoing double-balloon enteroscopy for obscure gastrointestinal bleeding. Aliment. Pharmacol. Ther. 29, 342-349 2009
82. Lewis, B. S., Eisen, G. M. & Friedman, S. A pooled analysis to evaluate results of capsule endoscopy trials. Endoscopy 37, 960-965 2005
83. Cobrin, G. M., Pittman, R. H. & Lewis, B. S. Increased diagnostic yield of small bowel tumors with capsule endoscopy. Cancer 107, 22-27 2006
84. Wiarda, B. M. et al. Small bowel Crohn's disease: MR enteroclysis and capsule endoscopy compared to balloon-assisted enteroscopy. Abdom. Imaging 37, 397-403 2012
85. Huprich, J. E. et al. Prospective blinded comparison of wireless capsule endoscopy and multiphase CT enterography in obscure gastrointestinal bleeding. Radiology 260, 744-751 2011
86. Ross, A. et al. Double balloon enteroscopy detects small bowel mass lesions missed by capsule endoscopy. Dig. Dis. Sci. 53, 2140-2143 2008
87. Bakaeen, F. G. et al. What prognostic factors are important in duodenal adenocarcinoma? Arch. Surg. 135, 635-641 2000
88. Abrahams, N. A., Halverson, A., Fazio, V. W., Rybicki, L. A. & Goldblum, J. R. Adenocarcinoma of the small bowel: A study of 37 cases with emphasis on histologic prognostic factors. Dis. Colon Rectum 45, 1496-1502 2002
89. Sohn, T. A. et al. Adenocarcinoma of the duodenum: Factors influencing long-term survival. J. Gastrointest. Surg. 2, 79-87 1998
90. Overman, M. J., Hu, C. Y., Wolff, R. A. & Chang, G. J. Prognostic value of lymph node evaluation in small bowel adenocarcinoma: Analysis of the surveillance, epidemiology, and end results database. Cancer 116, 5374-5382 2010
91. Nicholl, M. B. et al. Small bowel adenocarcinoma: understaged and undertreated? Ann. Surg. Oncol. 17, 2728-2732 2010
92. Edge, S., Byrd, D. R. & Compton, C. C. in AJCC Cancer Staging Manual, 7th edn Ch. 17 eds Edge, S. B. et al. 181-190 Springer, New York, 2010
93. Barnes, G. Jr, Romero, L., Hess, K. R. & Curley, S. A. Primary adenocarcinoma of the duodenum: Management and survival in 67 patients. Ann. Surg. Oncol. 1, 73-78 1994
94. Kaklamanos, I. G. et al. Extent of resection in the management of duodenal adenocarcinoma. Am. J. Surg. 179, 37-41 2000
95. Joesting, D. R., Beart, R. W. Jr, van Heerden, J. A. & Weiland, L. H. Improving survival in adenocarcinoma of the duodenum. Am. J. Surg. 141, 228-231 1981
96. Poultsides, G. A. et al. Duodenal adenocarcinoma: Clinicopathologic analysis and implications for treatment. Ann. Surg. Oncol. 19, 1928-1935 2012
97. Lepage, C., Bouvier, A. M., Manfredi, S., Dancourt, V. & Faivre, J. Incidence and management of primary malignant small bowel cancers: A well-defined French population study. Am. J. Gastroenterol. 101, 2826-2832 2006
98. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials IMPACT investigators. Lancet 345, 939-944 1995
99. Overman, M. J., Kopetz, S., Lin, E., Abbruzzese, J. L. & Wolff, R. A. Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine. Acta Oncol. 49, 474-479 2010
100. Singhal, N. & Singhal, D. Adjuvant chemotherapy for small intestine adenocarcinoma. Cochrane Database Systematic Reviews, Art. No.: CD005202, http://dx.doi.org/10.1002/14651858.CD005202.pub2.
101. Keat, N. et al. International rare cancers initiative. Lancet Oncol. 14, 109-110 2013
102. Swartz, M. J. et al. Adjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum. Arch. Surg. 142, 285-288 2007
103. Kelsey, C. R. et al. Duodenal adenocarcinoma: Patterns of failure after resection and the role of chemoradiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 69, 1436-1441 2007
104. Onkendi, E. O. et al. Neoadjuvant treatment of duodenal adenocarcinoma: A rescue strategy. J. Gastrointest. Surg. 16, 320-324 2012
105. Fishman, P. N. et al. Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: A retrospective review of 113 cases. Am. J. Clin. Oncol. 29, 225-231 2006
106. Koo, D. H. et al. Systemic chemotherapy for treatment of advanced small bowel adenocarcinoma with prognostic factor analysis: Retrospective study. BMC Cancer 11, 205 2011
107. Czaykowski, P. & Hui, D. Chemotherapy in small bowel adenocarcinoma: 10-year experience of the British Columbia Cancer Agency. Clin. Oncol. R. Coll. Radiol. 19, 143-149 2007
108. Ouriel, K. & Adams, J. T. Adenocarcinoma of the small intestine. Am. J. Surg. 147, 66-71 1984
109. Gibson, M. K., Holcroft, C. A., Kvols, L. K. & Haller, D. Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma. Oncologist 10, 132-137 2005
110. Overman, M. J. et al. Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater. J. Clin. Oncol. 27, 2598-2603 2009
111. McWilliams, R. R. et al. Pharmacogenetic dosing by UGT1A1 genotype as first-line therapy for advanced small-bowel adenocarcinoma: A North Central Cancer Treatment Group NCCTG trial [abstract]. J. Clin. Oncol. 30 Suppl. 4, a314 2012
112. Xiang, X. J. et al. A phase II study of modified FOLFOX as first-line chemotherapy in advanced small bowel adenocarcinoma. Anticancer Drugs 23, 561-566 2012
113. Locher, C. et al. Combination chemotherapy in advanced small bowel adenocarcinoma. Oncology 69, 290-294 2005
114. Zaanan, A. et al. Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan FOLFIRI regimen in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy: A multicentre AGEO study. Cancer 117, 1422-1428 2011
115. Zhang, L. et al. Efficacy of the FOLFOX/CAPOX regimen for advanced small bowel adenocarcinoma: A three-centre study from China. J. BUON 16, 689-696 2011
116. Jigyasu, D., Bedikian, A. Y. & Stroehlein, J. R. Chemotherapy for primary adenocarcinoma of the small bowel. Cancer 53, 23-25 1984
117. Crawley, C., Ross, P., Norman, A., Hill, A. & Cunningham, D. The Royal Marsden experience of a small bowel adenocarcinoma treated with protracted venous infusion 5-fluorouracil. Br. J. Cancer 78, 508-510 1998
118. Tsushima, T. et al. Multicenter retrospective study of 132 patients with unresectable small bowel adenocarcinoma treated with chemotherapy. Oncologist 17, 1163-1170 2012
119. Overman, M. J. et al. Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma. Cancer 113, 2038-2045 2008
120. Santini, D. et al. Cetuximab in small bowel adenocarcinoma: A new friend? Br. J. Cancer 103, 1305 2010
121. De Dosso, S., Molinari, F., Martin, V., Frattini, M. & Saletti, P. Molecular characterisation and cetuximab-based treatment in a patient with refractory small bowel adenocarcinoma. Gut 59, 1587-1588 2010
122. Jeurnink, S. M., van Eijck, C. H., Steyerberg, E. W., Kuipers, E. J. & Siersema, P. D. Stent versus gastrojejunostomy for the palliation of gastric outlet obstruction: A systematic review. BMC Gastroenterol. 7, 18 2007
123. Ercolani, G. et al. The role of liver resections for noncolorectal, nonneuroendocrine metastases: Experience with 142 observed cases. Ann. Surg. Oncol. 12, 459-466 2005
124. Adam, R. et al. Hepatic resection for noncolorectal nonendocrine liver metastases: Analysis of 1,452 patients and development of a prognostic model. Ann. Surg. 244, 524-535 2006